Kanada - Kiingereza - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 2.5mg - salbutamol (salbutamol sulfate) 2.5mg - selective beta 2-adrenergic agonists

Kanada - Kiingereza - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists

Kanada - Kiingereza - Health Canada

glaxo canada inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists

Kanada - Kiingereza - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 0.5mg - salbutamol (salbutamol sulfate) 0.5mg - selective beta 2-adrenergic agonists

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salbutamol sulfate - oral solution - 2 mg/5ml - selective beta-2-adrenoreceptor agonists; salbutamol

Malta - Kiingereza - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - salbutamol - oral solution - salbutamol 2 mg/5ml - drugs for obstructive airway diseases

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - salbutamol sulfate - oral solution - 400microgram/1ml

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml);   - syrup - 2 mg/5ml - active: salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml)   excipient: citric acid monohydrate hypromellose orange flavour 17-42-8187 purified water saccharin sodium sodium benzoate sodium chloride sodium citrate dihydrate - ventolin syrup is indicated for the treatment or prevention of bronchospasm. it provides short acting bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failing to respond to treatment with salbutamol may signal a need for urgent medical advice or treatment. ventolin syrup is suitable oral therapy for children or those adults who prefer liquid medicines.

Singapoo - Kiingereza - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - salbutamol sulphate eqv salbutamol - powder, metered - 200 mcg/inhalation - salbutamol sulphate eqv salbutamol 200 mcg/inhalation

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

glaxosmithkline (gsk) - salbutamol - solution for injection - 0.5 mg/ml